ARCHIVES

FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977

More Breast Cancer Patients Opt To Remove Both Breasts

November 26, 2010

ACS Asks Higher NCI Authorization

March 24, 1978

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

August 28, 1981

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990